Citadel Advisors
QGENF

Citadel Advisors’s QIAGEN NV QGENF Stock Holding History

Citadel Advisors’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-500
Closed -$13K – 9844
2015
Q3 		$13K Buy
+500
New +$13K ﹤0.01% 8396
2014
Q3 		– Sell
-10,200
Closed -$249K – 8880
2014
Q2 		$249K Buy
10,200
+8,600
+538% +$210K ﹤0.01% 5306
2014
Q1 		$34K Buy
1,600
+1,500
+1,500% +$31.9K ﹤0.01% 7028
2013
Q4 		$2K Buy
+100
New +$2K ﹤0.01% 6933

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Citadel Advisors's QGENF Position: Q1 2017 in Review

Citadel Advisors sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 619,249 shares — an estimated $17.4M sold.

Citadel Advisors first reported a position in QGENF in Q4 2013 and held it in 8 quarters. The position peaked at $28.1M in Q2 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Citadel Advisors reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Citadel Advisors sold 619,249 QIAGEN NV shares in Q1 2017, an estimated $17.4M.
  • Citadel Advisors first reported a position in QIAGEN NV in Q4 2013 and held it in 8 quarters.
  • Citadel Advisors's QIAGEN NV position peaked at $28.1M in Q2 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.